Appendix 2A — Fully Paid Ordinary Shares
August 4, 2020
Imagion Biosystems Limited announces Appendix 2A — Fully Paid Ordinary Shares. Read the announcement.
Category: Investor updates
Proposed Issue of Securities — IBXOA
August 4, 2020
Imagion Biosystems Limited announces the proposed issue of 1,500,000 options expiring 28 April, 2023. Read the announcement.
Proposed Issue of Securities — IBX
August 4, 2020
Imagion Biosystems Limited announces the proposed issue of 1,000,000 ordinary fully paid securities. Read the announcement.
Upcoming Release of Shares from Escrow
July 31, 2020
Imagion Biosystems Limited (ASX: IBX) (the Company) advises in accordance with Listing Rule 3.10A, that 2,500,000 Fully Paid Ordinary Shares will be released from voluntary
Quarterly Activity Report and Appendix C
July 29, 2020
Quarterly Activity Report – Period ending 30 June 2020 Q2 Highlights: Company announces plans for the Phase I first-in-human study to be undertaken in Australia
Proposed Issue of Securities — IBX
July 29, 2020
Imagion Biosystems Limited has announced a Proposed Issue of Securities. Read the Proposed Issue of Securities.
Proposed Issue of Securities — IBXOA
July 29, 2020
Imagion Biosystems has announced a Proposed Issue of Securities. Read the Proposed Issue of Securities.
IBX Raises $5M in Oversubscribed Placement
July 29, 2020
$5M raised in an oversubscribed placement at 4.5c per share – equivalent to 30 day VWAP, and a 33.9% premium to 60 day VWAP. Strongly
Appendix 2A
July 28, 2020
The application for quotation (Appendix 2A) for listed options (IBCOA) was released to the market. Read Appendix 2A.
Trading Halt
July 27, 2020
The securities of Imagion Biosystems Limited (‘IBX’) will be placed in trading halt at the request of IBX, pending it releasing an announcement regarding a